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THERAPEUTIC ADVANCES IN DRUG SAFETY 
FUTURE PERSPECTIVES ON NON-MEDICAL PRESCRIBING 
Derek Stewart, Tesnime Jebara, Scott Cunningham, Ahmed Awaisu, Abdulrouf 
Pallivalapila, Katie MacLure 
 
ABSTRACT 
Many countries have implemented non-medical prescribing (NMP) and many others are 
scoping prescribing practices with a view to developing NMP. This paper provides a 
future perspective on NMP in light of the findings of an umbrella review of aspects of 
NMP. This is followed by coverage of the Scottish Government strategy of pharmacist 
prescribing and finally consideration of two key challenges.  
The review identified seven systematic reviews of influences on prescribing decision-
making, processes of prescribing and barriers and facilitators to implementation. 
Decision-making was reported as complex with many, and often conflicting, influences. 
Facilitators of NMP included perceived improved patient care and professional autonomy 
while barriers included lack of defined roles and resource pressures.  
Three systematic reviews explored patient outcomes which were noted to be equivalent 
or better to physician prescribing. In particular, a Cochrane review of 46 studies of 
clinical, patient-reported, and resource use outcomes of NMP compared with medical 
prescribing showed positive intervention group effects. Despite positive findings, authors 
highlighted high bias, poor definition and description of ‘prescribing’ and the ‘prescribing 
process’ and difficulty in separating NMP effects from the contributions of other 
healthcare team members.  
While evidence of benefit and safety is essential to inform practice, for NMP to be 
implemented and sustained on a large scale, there needs to be clear commitment at the 
highest level. The approach being taken by the Scottish Government to pharmacist 
prescribing implementation may inform developments in other professions and countries. 
The vision is that by 2023, all pharmacists providing pharmaceutical care will be 
pharmacist independent prescribers. There are, however, challenges to implementing 
NMP into working practice; two key challenges are the need for sustainable models of 
care and evaluation research. These challenges could be met by considering the 
theoretical basis for implementation, and robust and rigorous evaluation.  
  
FUTURE PERSPECTIVES ON NON-MEDICAL PRESCRIBING 
 
Non-medical prescribing models 
The roles and responsibilities of all health professionals have undergone tremendous 
transformation in recent years. One key development has been the implementation of 
prescribing by non-medical health professionals across many countries including 
Australia, Ireland, New Zealand, the United Kingdom (UK) and the United States (US) 
[Stewart et al. 2012]. Many other countries are scoping current prescribing practices 
with a view to developing non-medical prescribing (NMP) models. A range of health 
professionals (e.g. dieticians, nurses, pharmacists, physiotherapists, radiographers) now 
have prescribing rights. The specific professions, their training and accreditation, and 
models of prescribing practice vary in different countries. Specific aims of NMP vary from 
country to country but are focused generally on: improving patient care outcomes 
without compromising patient safety; increasing patient access to medicines; and 
making better use of the skills of health professionals [Stewart et al. 2012, Cope et al. 
2016].  
 
For example, in the UK, there are two models of NMP: supplementary prescribing (SP) 
and independent prescribing (IP). SP, introduced in 2003, is defined as a ‘voluntary 
partnership between an independent prescriber (doctor or dentist) and a supplementary 
prescriber to implement an agreed patient-specific clinical management plan (CMP) with 
the patient’s agreement’ [Department of Health, 2003]. A later development was the 
introduction in 2006 of IP, defined as ‘prescribing by a practitioner (e.g. doctor, dentist, 
nurse, pharmacist) responsible and accountable for the assessment of patients with 
undiagnosed or diagnosed conditions and for decisions about the clinical management 
required, including prescribing’ [Department of Health, 2006]. Qualification as an 
independent prescriber now also confers supplementary prescribing status. The 
similarities and differences between SP and IP are summarised in Table 1. 
  
 Table 1: Scope of Different Models of NMP in the UK [Adapted from Stewart et al. 2012] 
 Supplementary Prescribing Independent Prescribing 
Eligible health 
professionals  
Dieticians, nurses, optometrists, 
pharmacists, physiotherapists, 
podiatrists, radiographers  
Nurses, optometrists, 
pharmacists, physiotherapists, 
podiatrists, therapeutic 
radiographers   
Clinical conditions 
managed 
Any, within their clinical 
competence 
Any, within their clinical 
competence 
Diagnosis 
responsibilities 
A doctor (or dentist) must 
diagnose the condition before 
prescribing can commence 
The independent prescriber 
can assess and manage 
patients with diagnosed or 
undiagnosed conditions 
Need for CMP A written or electronic patient-
specific CMP must be in place 
before prescribing can commence 
No need for a CMP 
Need for formal 
agreement  
The CMP must be agreed with 
the doctor (or dentist) and 
patient before prescribing can 
commence 
No need for any formal 
agreement 
Drugs prescribed Any, within their clinical 
competence 
Any licensed medicines within 
their clinical competence. 
Nurse and pharmacist 
independent prescribers in 
particular can prescribe 
unlicensed medicines and 
controlled drugs 
 
In a recent paper in this journal, Cope et al. described the development of NMP, the 
processes required to qualify in the UK and the potential influences on NMP practice 
[Cope et al. 2016]. In the remainder of this paper, we consider the complexities of 
prescribing in general and in relation to NMP, followed by an umbrella review of all 
published systematic literature reviews on aspects of NMP, detailed coverage of the 
policy driven Scottish Government strategy relating to pharmacist prescribing and reflect 
on the future of NMP in light of accumulated evidence.  
 
Complexities of prescribing  
The ten principles of good prescribing, articulated by the British Pharmacological Society, 
underline that prescribing is a complex and challenging task requiring considerable 
knowledge, skills and self-belief in capabilities (Box 1).  
 
 
 
 
 
 
 
Box 1. Ten principles of good prescribing, British Pharmacological Society (2016). 
1. Be clear about the reasons for prescribing 
2. Take into account the patient’s medication history before prescribing 
3. Take into account other factors that might alter the benefits and risks of treatment 
4. Take into account the patient’s ideas, concerns and expectations 
5. Select effective, safe, and cost-effective medicines individualised for the patient 
6. Adhere to national guidelines and local formularies where appropriate 
7. Write unambiguous legal prescriptions using the correct documentation 
8. Monitor the beneficial and adverse effects of medicines  
9. Communicate and document prescribing decisions and the reasons for them 
10.  Prescribe within the limits of your knowledge, skills and experience 
 
These principles apply to all prescribers, and should be borne in mind as new 
professional groupings are afforded prescribing rights. Point 10 is especially pertinent for 
newly qualified non-medical prescribers who, despite being experienced practitioners, 
are inexperienced prescribers and must be prepared to seek the advice and support of 
their professional colleagues.  
Given the evidence base demonstrating widespread suboptimal prescribing by doctors, 
there is great potential for non-medical prescribers to impact positively patient care and 
safety. Ross et al. reported a systematic review of prescribing errors by junior doctors, 
with error prevalence rates of between 2 and 514 per 1000 items prescribed and in 4% 
to 82% of patients or charts reviewed [Ross et al. 2009]. Similarly, a systematic review 
by Lewis et al. of all prescribing errors in hospital inpatients reported median error 
prevalence data of 7% (interquartile range 2–14%) of medication orders, 52 (8–227) 
errors per 100 admissions and 24 (6–212) errors per 1000 patient days [Lewis et al. 
2009]. As non-medical prescribers must have several years’ experience of interacting 
with patients prior to commencing their prescribing training, it could be hypothesised 
that this experience, together with specific prescribing training and assessment of 
competence, will translate into safer, more appropriate prescribing. To date, however, 
there has been little published research on NMP error rates. In one small study 
conducted in three hospitals in England, pharmacists prescribing of 1,415 items revealed 
errors in only four items (0.3%) [Baqir et al. 2015]. While this appears to be positive, 
there is a need for further large scale research to confirm safety and appropriateness of 
all NMP. 
One future development in the preparation of all prescribers (medical and non-medical) 
may be harmonisation of training, assessment, registration and regulation processes. 
Indeed, the National Prescribing Centre (now part of the National Institute for Health and 
Clinical Excellence for England and Wales) has produced a single competency framework 
for all prescribers [National Prescribing Centre, 2012]. The framework comprises 72 
competency statements, organised into nine themed areas of knowledge, options, 
shared decision making, safe, professional, always improving, the healthcare system, 
information, self and others, in three overarching domains of the consultation, 
prescribing effectively and prescribing in context. It is anticipated that, if acquired and 
maintained, these competencies will help all prescribers become and remain effective 
and safe in their area of practice.  
Non-medical prescribers’ training, achieving these competencies and ongoing continuing 
professional development may lead to safe and effective prescribing. There remains, 
however, a need for robust and rigorous evidence of NMP safety and effectiveness on 
which to base future developments. While there are multiple published literature reviews 
exploring different aspects of NMP, to date there has been no comprehensive overview. 
Such a review would summarise the evidence from multiple research syntheses and 
provide an assessment of the body of evidence to further inform developments.  
 
Reviews of non-medical prescribing 
Aim 
Umbrella reviews provide synthesis of the findings of systematic reviews [Aromataris et 
al. 2015]. Conducting such a review such involves examining the quality of the included 
systematic review but does not require repeating the searches, assessment of study 
eligibility or quality assessment of the included reviews. The focus is on providing an 
overall picture of findings for the particular umbrella review aim. The aim of this 
umbrella review was to collate and summarize all the published systematic reviews on 
NMP in order to report aspects, including, but not limited to: models and definitions; 
legal frameworks; outcomes and benefits; perceptions and satisfaction of different 
stakeholders (e.g. general public, patients, health professionals and decision makers); 
and facilitators and barriers to implementing NMP. The search was conducted between 
March and November 2016.  
 
Method  
Search strategy 
Systematic reviews meeting the above criteria and published in English were included in 
the review. The following electronic bibliographic databases were searched: Medline, 
Cumulative Index of Nursing and Allied Health Literature, Science Direct, International 
Pharmaceutical Abstracts and Google Scholar. The Cochrane Library, the Centre for 
Reviews and Dissemination (Prospero) and Joanna Briggs Institute databases were also 
searched to identify any registered systematic review protocols. The reference lists of 
the retrieved reviews were examined to locate any further reviews.  
 
The search strategy included only terms relating to or describing NMP, with no limits 
placed on the search. Alerts were created to check for further reviews for inclusion while 
conducting the review. An example of the search for Medline is given in Box 2. 
 
 
Box 2. Medline search string 
("non-medical prescrib*" OR "non medical prescrib*" OR NMP OR "pharmac* 
prescrib*" OR "nurse* prescrib*" OR "midwi* prescrib*" OR "podiatrist* prescrib*" OR 
"chiropodist* prescrib*" OR "optometrist* prescrib*" OR "orthoptist* prescrib*" OR 
"optician* prescrib*" OR "physiotherapist* prescrib*" OR "physical therapist* 
prescrib*" OR "dieti* prescrib*" OR "occupational therapist* prescrib*" OR 
"paramedic* prescrib*" OR "radiographer* prescrib*" OR "respiratory therapist* 
prescrib*" OR "audiologist* prescrib*") AND (review) 
 
Title, abstract and full text screening and assessment for inclusion was conducted by one 
of the reviewers (TJ), with another (DS) reviewing independently a 10% random sample 
to ensure sensitivity (comprehensiveness of search) and specificity (precision and 
relevance of reviews retrieved). Any disagreements were resolved through discussion 
without having to consult a third reviewer. 
 
Quality assessment 
The quality of systematic reviews that met the inclusion criteria was assessed using the 
Critical Appraisal Skills Programme (CASP) tool [CASP, 2016]. Quality assessment was 
conducted independently by two reviewers (TJ and DS or KM or SC or AA or ARP) and 
disagreements resolved through discussion without having to consult a third reviewer. 
  
Data extraction 
The characteristics of the included reviews were extracted and summarised in tables. 
Data extracted were: authors; year of publication; country/countries of focus; type of 
review; objectives; NMP definition; databases searched; number of articles; and major 
findings. As with the quality assessment, data extraction was undertaken independently 
by two reviewers. 
 
Data synthesis 
Due to heterogeneity of reviews in terms of objectives and data, a narrative synthesis 
was most appropriate.  
 
Results 
Searching identified 528 studies, which was reduced to 453 after removing duplicates. 
Four hundred and five were excluded on review of titles and abstracts (no search 
strategy included or not related to NMP) leaving 48, with two more identified from 
reference lists making 50. Full-text screening excluded a further 26 (reasons as before). 
Of the remaining 24, there were 13 non-systematic reviews, 4 were protocols leaving 7 
systematic reviews for quality assessment, data extraction and synthesis. The PRISMA 
flow chart is provided in Figure 1.   
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: PRISMA flow chart detailing the inclusion process 
 
Quality assessment 
The quality assessment of the seven systematic reviews is given in Table 2. Most were 
deemed of high quality, although one would have benefited from searching country 
specific databases and lacked quality assessment [Kroezen et al. 2011], and qualitative 
findings could have been subjected to meta-synthesis in another [Ness et al. 2016].  
 
Data extraction 
Systematic reviews 
(n=7)  
Systematic review 
protocols (n=4)  
Other types of review 
(n=13) 
Full-text articles 
included in qualitative 
synthesis 
(n=24) 
Records identified through 
database searching 
(n=528) 
Records excluded (n=405) 
- not NMP related (n=303) 
- not a review (n=102) 
Records for screening 
(duplicates removed) 
(n=453) 
Full-text assessed for 
eligibility 
(n=48) 
Full-text excluded (n=26) 
- not NMP related (n=9) 
- not a review (n=12) 
- not in English (n=1) 
- no full text available (n=4) 
Records identified 
through reference 
list searching  
(n=2) 
The data extraction is given in Table 3. Five focused solely on nurse prescribing [Van 
Ruth et al. 2007, Kroezen et al. 2011, Darvishpour et al. 2014, Gielen et al. 2014, Ness 
et al. 2016] with two  discussing all non-medical prescribers [McIntosh et al. 2016, 
Weeks et al. 2016]. While five included all studies irrespective of country or setting [Van 
Ruth et al. 2007, Darvishpour et al. 2014, Gielen et al. 2014, Ness et al. 2016, Weeks et 
al. 2016], one included only those conducted in Western European and Anglo-Saxon 
countries [Kroezen et al. 2011], and one was restricted to the UK [McIntosh et al. 2016]. 
The number of studies reviewed ranged from three to 124. Two reviews focused on 
aspects of influences on prescribing decision-making generally [McIntosh et al. 2016] 
and prescribing behaviour related to antimicrobials [Ness et al. 2016]. One reported the 
extent of implementation of nurse prescribing [Kroezen et al. 2011], one processes of 
prescribing and associated barriers and facilitators to implementation [Darvishpour et al. 
2014], with three on various patient outcome measures [Van Ruth et al. 2007, Gielen et 
al. 2014, Weeks et al. 2016].  
 
Synthesis of findings 
Decision making and prescribing behaviours were reported as complex with many, and 
often conflicting, influences [McIntosh et al. 2016, Ness et al. 2016]. Of the three 
studies reviewed by McIntosh et al. [2016] decision-making was not the primary aim for 
any. Acknowledging the paucity of studies and limited evidence base, key influences on 
decision-making included non-medical prescribers’ experience, evidence based guidelines 
and treatment protocols, peer support and encouragement from medical practitioners, 
and patients. Ness et al. [2016] reported similar influences on decision-making in 
relation to antibiotic prescribing in the seven studies reviewed. Patient and parent 
pressure was noted as a key influence in both the decision to prescribe and which 
antibiotic to prescribe. These two systematic reviews have highlighted the need for 
further research on the decision-making processes, decisions and prescribing behaviours 
of non-medical prescribers to inform NMP education, training and practice.  
 
Facilitators of NMP included perceived improved patient care, professional autonomy and 
potential to apply expertise while barriers included lack of clearly defined roles of non-
medical prescribers, time for prescribing activities and other resource pressures such as 
lack of funding to support prescribing roles, other competing tasks, lack of confidence of 
some NMPs, and the lack of acceptance of the role by other health professionals and 
patients. [Darvishpour et al. 2014]. This review was a meta-synthesis of 11 qualitative 
studies. There would be merit in updating this review to incorporate qualitative, 
quantitative and mixed methodology studies but with focus on how facilitators are 
enabled and barriers overcome. Findings would assist greatly the development and 
implementation of NMP in new settings and countries.  
 
Three systematic reviews have now been published reporting data on patient outcomes. 
[Van Ruth et al. 2007, Gielen et al. 2014, Weeks et al. 2016]. Despite the largely 
positive findings on a variety of outcome measures, the review authors all highlighted 
the absence of well-designed RCTs and high levels of bias associated with many of the 
studies included in their reviews which often resulted in the outcomes findings being 
downgraded. In addition, the review authors noted the issue of often poor definition and 
description of ‘prescribing’ and the ‘prescribing process’ within many studies, and the 
difficulty in separating NMP effects from the contributions of other members of the 
healthcare team. Review findings should therefore be interpreted with great caution. In 
2007, Van Ruth et al. reported their review of 23 studies of nurse prescribing. Of the 
nine studies reporting clinical outcomes, there were no differences between nurses and 
GPs in terms of resolution of symptoms, health status rating, clinical improvement over 
two weeks. These studies included ‘various’ patients, those presenting acutely with sore 
throats, need for contraception and the chronic condition of diabetes mellitus hence 
limiting the opportunity for data pooling. In 2014, Gielen et al. reported a systematic 
review of 35 studies of nurse prescribing. Of the 13 studies reporting clinical outcomes, 
there were no differences between nurse and physician prescribing in a variety of 
conditions including diabetes, hypertension, asthma, sore throat and contraception. The 
heterogeneity of patient populations and outcome measures limited the potential for any 
data pooling. Very recently, Weeks et al. [2016] reported a Cochrane review of 46 
studies (26 nurse and 20 pharmacist prescribers) of clinical, patient-reported, and 
resource use outcomes of NMP for managing acute and chronic health conditions in 
primary and secondary care settings compared with medical prescribing. A meta-analysis 
of outcome measures of chronic disease showed positive intervention group effects. 
There was a moderate-certainty of evidence for studies of blood pressure at 12 months 
(12 studies, 4229 participants) and low-density lipoprotein (7 studies, 1469 
participants). Patients were generally satisfied with non-medical prescriber care (14 
studies, 7514 participants). A wide variety of resource use measures were reported 
across studies with little difference between groups for hospitalisations, emergency 
department visits, and outpatient visits. The authors concluded that there remains a 
need for well designed, conducted and reported randomised controlled trials of NMP 
compared to medical prescribing. However, as NMP is implemented increasingly into 
practice, there may be less desire from policy makers, healthcare leaders and funders to 
support such studies, preferring instead robust, rigorous evaluation of real life practice. 
 
 
Table 2. Quality assessment of the six systematic reviews [CASP 2016] 
 
 
Authors (Year) 
Are the results of the review valid? What are the results? Will the results help locally? 
Review 
addressed 
a clearly 
focused 
issue  
Search 
relevant 
Important 
and 
relevant 
studies 
included 
Rigorous 
assessment 
of quality of 
included 
studies 
Reasonable 
to combine 
results of 
review 
Overall results 
of review 
Precision of 
results 
appropriate 
 
Applicable to 
local 
population 
 
All important 
outcomes 
considered 
Van Ruth et al. 
(2007) 
Yes Yes Yes Yes 
 
Yes, pooled 
if 
homogenous 
(for one 
review 
question)  
but noted 
high risk of 
bias in some 
studies 
 
Very clear 
presentation of 
results 
according to 
aim  
Yes (pooled 
data) 
N/A Yes 
Kroezen et al. 
(2011) 
Yes Partially 
(peer 
reviewed 
literature 
less 
appropriate 
for some 
questions, 
e.g. extent 
of legal, 
educational 
conditions)  
Partially No explicit 
coverage of 
quality 
assessment 
N/A as no 
meta-
analysis or 
meta-
synthesis 
Very clear 
presentation of 
results 
according to 
aim 
N/A as no 
pooling  
N/A Yes 
  
Gielen et al. 
(2014) 
Yes Yes Yes Yes Yes, pooled 
if 
homogenous 
but noted 
high risk of 
bias in some 
studies 
Very clear 
presentation of 
results 
according to 
aim 
Yes (pooled 
data) 
N/A Yes 
Darvishpour et 
al. (2014) 
Yes Yes Yes Yes Yes, 
qualitative 
meta-
synthesis 
Very clear 
presentation of 
results 
according to 
aim 
N/A for meta-
synthesis 
N/A Yes 
McIntosh et al. 
(2016) 
Yes Yes Yes Yes Yes, 
qualitative 
meta-
synthesis 
Very clear 
presentation of 
results 
according to 
aim 
N/A for meta-
synthesis 
N/A Yes 
Ness et al. 
(2016) 
Yes Yes Yes Yes No meta-
synthesis of 
qualitative 
studies 
given  
Very clear 
presentation of 
results 
according to 
aim 
N/A for meta-
synthesis 
(although not 
conducted) 
N/A Yes 
Weeks et al. 
(2016) 
Yes Yes Yes Yes 
 
Yes, pooled 
if 
homogenous 
but noted 
high risk of 
bias in some 
studies 
 
Very clear 
presentation of 
results 
according to 
aim  
Yes (pooled 
data) 
N/A Yes 
Table 3. Data extraction of six systematic reviews 
Authors 
(Year) 
Aims/ Objective(s) Country NMP  Databases searched and search 
terms used 
Number 
of 
articles  
Findings 
Van Ruth et 
al. (2007) 
Aimed to review the effects of 
medication being prescribed by 
nurses. 
 
The following research questions 
were addressed: what are the 
effects of nurse prescribing 
compared to physician prescribing, 
on the quantity and types of 
medication being prescribed?; 
what are the effects of nurse 
prescribing on patient outcomes?; 
what are the effects of nurse 
prescribing on physician and nurse 
outcomes?; what are the effects of 
nurse prescribing on 
characteristics of the health care 
system? 
Review of 
all studies, 
irrespective 
of country 
Nurse 
prescribing 
Pubmed, Embase, CINAHL, 
Cochrane Library, Picarta, SCI, 
Invert, Biomed central, Virginia 
Henderson Library, Current 
Control Trials, NIVEL catalog, UK 
Department of Health, World 
Health Organisation, Nurse 
Prescriber website, Google 
 
For Pubmed, the following search 
terms were used: (“Nurse 
prescribing”) OR (Nurs* [tiab] 
AND Prescri* [tiab]) 
OR (Nurs* AND prescriptions, 
drug [MeSH]) 
23 Nurses sometimes differed from 
physicians in the number of patients 
they prescribe for and in the choice of 
type of medication. 
 
Clinical parameters were the same or 
better for treatment by nurses compared 
to physicians across a range of 
conditions (diabetes and ‘various’) 
 
Perceived quality of care by nurses was 
similar or better. 
 
The effects on professionals or on the 
health care system could not be 
described. 
Kroezen et 
al. (2011) 
Aimed to gain insight into the 
scientific and professional 
literature describing the extent to 
and the ways in which nurse 
prescribing has been realised or is 
being introduced in Western 
European and Anglo-Saxon 
countries.  
Secondly, to identify possible 
mechanisms underlying the 
introduction and organisation of 
Western 
European 
and Anglo-
Saxon 
countries 
Nurse 
prescribing 
PubMed, Embase, CINAHL, Web 
of Science, EBSCO, NIVEL, 
Virginia Henderson International 
Nursing Library, WHO website, 
Health professionals’ website, 
Google scholar. 
 
 
The following keywords were 
used: “nurse prescribing”, 
124 Seven countries had implemented nurse 
prescribing of medicines. 
The Netherlands and Spain were in the 
process of introducing nurse prescribing. 
 
 
nurse prescribing on the basis of 
Abbott’s theory on the division of 
professional labour. 
“independent (nurse) 
prescribing”, “autonomous 
prescribing”,  “supplementary 
(nurse) prescribing”, “dependent 
(nurse) prescribing”, 
“collaborative prescribing”, 
“group protocols” “patient group 
directions”, “time and dose 
prescribing”, “nurse formulary” 
A diversity of external and internal 
forces had led to the introduction of 
nurse prescribing internationally. 
 
The legal, educational and organizational 
conditions under which nurses prescribe 
medicines varied considerably between 
countries; from situations where nurses 
prescribed independently to situations in 
which prescribing by nurses was only 
allowed under strict conditions and 
supervision of physicians. 
Darvishpour 
et al. (2014) 
Aimed to obtain new insights on 
nurse prescribing drugs, and to 
present a schematic model of 
Nurse prescribing that could be a 
useful framework for its 
implementation.  
The following research questions 
were addressed: what is the 
overall view on nurse prescribing?; 
what are the positive and negative 
outcomes of nurse prescribing?; 
what are the barriers and 
facilitators for its implementation? 
 
 
Review of 
all studies, 
irrespective 
of country 
Nurse 
prescribing 
Integrated Digital National 
Library of Medicine, CINAHL, 
Medline, Cochrane Library, 
Scopus, Web of science, Elsevier, 
Emelard, JAMA journals, Wiley, 
Oxford journals, Springer and 
Thieme journals, WHO website, -
Nurse prescriber website, Google 
scholar, Cambridge journals 
website 
 
The following were used: review 
AND nurs* prescri*. 
 
 
11 Studies revealed eight themes namely: 
leading countries in prescribing, views, 
features, infrastructures, benefits, 
disadvantages, facilitators and barriers 
of nursing prescribing. 
 
Despite the positive view on nurse 
prescribing, there were still issues such 
as legal, administrative, weak research 
and educational deficiencies in academic 
preparation of nurses. 
Gielen et al. 
(2014) 
 
Aimed to identify, appraise and 
synthesise the evidence presented 
in the literature on the 
Review of 
all studies, 
irrespective 
of country 
Nurse 
prescribing 
BioMed Central, CINAHL, 
Cochrane Database of 
Systematic Reviews, Current 
Controlled Trials, Embase, 
35 Nurses prescribed in comparable ways to 
physicians. They prescribed for equal 
numbers of patients and prescribe 
 effectiveness of nurse prescribing 
compared to physician prescribing. 
 
The following research questions 
were addressed: what are the 
effects of nurse prescribing on the 
quantity and types of medication 
being prescribed?; what are the 
effects of nurse prescribing on 
patient outcomes?  
INVERT (Dutch nursing literature 
index), NIVEL catalogue, PiCarta 
(Dutch library system), PubMed, 
Science Citation Index and the 
Virginia Henderson International 
Nursing Library, and the website 
of the UK Department of Health, 
the website of the World Health 
Organisation, a website for 
health professionals and Google 
Scholar  
 
For Pubmed: 
(“Nurse prescribing”) OR (Nurs* 
[tiab] AND Prescri* [tiab]) OR 
(Nurs* AND prescriptions, drug 
[MeSH]) 
 
comparable types and doses of 
medicines.  
Studies comparing the total amount of 
medication prescribed by nurses and 
doctors show mixed results.  
 
There appeared to be few differences 
between nurses and physicians in patient 
health outcomes: clinical parameters 
were the same or better for treatment 
by nurses, perceived quality of care was 
similar or better and patients treated by 
nurses were just as satisfied or more 
satisfied. 
McIntosh et 
al. (2016) 
To critically appraise, synthesize 
and present evidence on the 
influences on prescribing decision-
making among supplementary and 
independent non-medical 
prescribers in the UK. 
UK All non-
medical 
prescribers  
Medline, PsycARTICLES, CINAHL, 
International Pharmaceutical 
Abstracts, Education Resources 
Information Centre, Cochrane 
Library, Google Scholar, 
reference lists 
 
The following search terms were 
used: prescrib* and 
(pharmacist* or nurse* or 
physiotherapist* or podiatrist* or 
radiographer* or optometrist*) 
and (influenc* or decision* or 
decid* or judge* or factor*) 
3 While all studies reported aspects of 
prescribing decision-making, this was 
not the primary research aim for any. 
 
Studies were carried out in primary care 
almost exclusively among nurse 
prescribers (n = 67). 
 
 
Complex influences were evident such as 
experience in the role, the use of 
evidence-based guidelines and peer 
support and encouragement from 
doctors; these helped participants to feel 
more knowledgeable and confident about 
their prescribing decisions. 
 
Opposing influences included 
prioritization of experience and concern 
about complications over evidence base, 
and peer conflict. 
 
Ness et al. 
(2016) 
To present the findings of a 
systematic review which explored 
the influences on the antimicrobial 
prescribing behaviour of 
independent nurse prescribers. 
Review of 
all studies, 
irrespective 
of country 
Independent 
nurse 
prescribing 
Medline, CINAHL, AMED, 
HealthSource Nursing/Academic 
Edition, Proquest Health, 
Internurse, Cochrane Database, 
Web of Knowledge, Index to 
Thesis, ETHOS, reference lists 
 
Search terms included: 
Prescri* AND Antibiotic OR 
antimicrobial OR antibacterial 
AND Nurs* 
7 Three articles expected that an 
antimicrobial would be given and 
therefore influences discussed were on 
the choice of the antimicrobial. 
Guidelines/protocols, safety, tolerability 
and efficacy of the antimicrobial itself, 
patient/parent pressure and 
training/experience were mentioned as 
influencing factors within the reported 
studies. 
 
The other four studies explored 
influences on whether to prescribe an 
antimicrobial or not and also found that 
guidelines/protocols were an influencing 
factor, however, the influence occurring 
most frequently was diagnostic 
uncertainty. 
 
Weeks et al. 
(2016) 
To assess clinical, patient-
reported, and resource use 
outcomes of non-medical 
prescribing for managing acute 
and chronic health 
conditions in primary and 
secondary care settings compared 
with medical prescribing (usual 
care). 
Review of 
all studies, 
irrespective 
of country 
Healthcare 
providers 
who were 
not medical 
doctors, 
undertaking 
prescribing 
including, 
nurses, 
Cochrane Database, DARE, HTA, 
Medline, Embase, PsycINFO, 
CINAHL. grey literature, trial 
registries 
 
 
46 A meta-analysis of surrogate markers of 
chronic disease (systolic blood pressure, 
glycated haemoglobin, and low-density 
lipoprotein) showed positive intervention 
group effects. 
 
While there appeared little difference in 
medication adherence across studies, a 
meta-analysis of continuous outcome 
optometrist, 
pharmacists, 
physician 
assistants, 
and other 
allied health 
professionals 
or categories 
not 
specifically 
mentioned 
whose roles 
met the 
definition of 
nonmedical 
prescribing 
data from four studies showed an effect 
favouring patient adherence in the non-
medical prescribing group. 
 
Patients were generally satisfied with 
non-medical prescriber care. 
 
 
 
 
 
 
 
 
Policy driven approach to NMP in Scotland: pharmacist prescribing as an 
exemplar 
While evidence of benefit and safety of NMP is essential to inform practice, for NMP to be 
implemented successfully and sustained on a large scale, there needs to be clear 
commitment at the highest level. This section provides a description of the Scottish 
Government strategy around the implementation of pharmacist prescribing; the 
approach and specific outcomes and actions described could be an exemplar for other 
professions and other countries. The Scottish Government strategy is to ensure that ‘all 
patients, regardless of their age and setting of care, will receive high quality 
pharmaceutical care using the clinical skills of the pharmacist to their full potential’ [The 
Scottish Government, 2013]. Prescription for Excellence: a Vision and Action Plan for the 
right pharmaceutical care through integrated partnerships and innovation, was published 
by the Scottish Government in September 2013. The vision articulated within this 
document is that by 2023, ‘all pharmacists providing National Health Service (NHS) 
pharmaceutical care will be NHS accredited clinical pharmacist independent prescribers 
working in collaborative partnerships with medical practitioners who will continue to have 
overall responsibility for diagnosis’. Much of the recommendations are based on a 
scoping review of pharmaceutical care of patients in the community in Scotland, 
undertaken by Wilson and Barber [Wilson et al. 2013]. There were several drivers for 
this landmark review including: the increasing work pressures in the NHS; the imminent 
lack of clinical capacity of the medical workforce; and an increasingly multimorbid older 
population with complex medicines related needs. There was recognition that ‘significant 
changes will occur in medicine and therapeutics which will require new and innovative 
models of care to enable patients to obtain the maximum benefit’ [The Scottish 
Government, 2013]. 
 
Enhancing and supporting the implementation of pharmacist IP to ensure patient-
centred, safe, effective and efficient pharmaceutical care is fundamental to the delivery 
of the ambitions of Prescription for Excellence. Key specific outcomes include: 
 
 pharmacists in the NHS would be recognised as clinicians responsible for  
the provision of NHS pharmaceutical care 
 releasing capacity of pharmacists to deliver pharmaceutical care would be 
facilitated by full utilisation of pharmacy technicians, support staff and 
increased use of robotics in dispensing to improve safety and efficiency 
 all patients would have access to NHS pharmaceutical care by NHS accredited 
clinical pharmacist independent prescribers in all settings  
 patients have a close relationship with an individual pharmacist, ensuring greater 
continuity and consistency of care for patients - introducing the concept of the 
named pharmacist and patient registration with NHS Board listed pharmacists 
which will underpin professional relationship with patients and local clinical 
governance systems. 
 
There is an associated workplan to ensure that these outcomes (and others) are 
achieved within the ten year timeframe. This includes developing approaches to: 
 embed partnership working between the patient (and/or carer), their GP and 
pharmacist – therapeutic partnerships - and with other health and social care 
professionals 
 further enhance the role of pharmacist IPs who will work with GPs to deliver 
medication/polypharmacy reviews, using telehealthcare and domiciliary visits, 
where appropriate 
 further develop the pharmacist’s contribution to the management of common 
clinical conditions and develop new models of delivery of primary care services in 
partnership with GPs 
 explore making better use of pharmacist prescribing post diagnosis. 
 
There are clearly wide ranging implications for all involved in the education, training and 
regulation of the pharmacy workforce as well as all other health and social care 
professionals with whom the pharmacist IP will work and patients, their families and 
carers, as well as the general public. These are highlighted in terms of: 
 
 ensuring a workforce that is fit for purpose by implementation of NHS standards 
of practice for pharmaceutical care are attained through working with the NHS, 
Schools of Pharmacy and Medicine, NHS Education for Scotland and the 
professional and regulatory bodies 
 ensuring education and training meets the needs of patients and the NHS 
 implementation of primary and secondary care configured systems to allow 
electronic information sharing contributing to pharmaceutical care and electronic 
prescribing for all prescribers including pharmacist IPs. 
 
It is, therefore, reassuring that specific reference is made to supporting ‘action research, 
practice research and clinical research that enables development and evaluation of 
pharmaceutical care’. Governance arrangements have been put in place to ensure 
delivery of the work programme and vision. These comprise: a Steering Board of key 
Scottish Government and NHS contacts to oversee and prioritise implementation; a 
Reference Group of a wide range of stakeholders to act as a sounding board; a Core 
Implementation/Management Group of the leads to oversee the working groups; and 
Working Groups developing a response to each action point contained in Prescription for 
Excellence.  
There are now over 750 pharmacists in Scotland (around 20%) who are either 
pharmacist IPs or have commenced training with the potential to make a difference to 
patient care in line with the ambitions of Prescription for Excellence. A recent survey of 
pharmacist prescribers across Great Britain, conducted by the General Pharmaceutical 
Council, highlighted that almost three quarters of the respondents were active 
prescribers, with the three major areas of prescribing being antibiotics, pain 
management and cardiovascular agents [General Pharmaceutical Council, 2016]. 
Barriers to prescribing cited included lack of resources and support networks, 
opportunity to prescribe and recognition of the prescribing role. These issues have been 
demonstrated repeatedly in previous research focusing on pharmacists in Great Britain, 
as well as in other countries and groups of IPs in systematic reviews [Van Ruth et al. 
2007, Kroezen et al. 2011, Darvishpour et al. 2014]. It is, therefore, vital that these 
issues of structures and processes are dealt with rigorously as Prescription for Excellence 
progresses in order to ensure the very best outcomes for patients. There is also a need 
to ensure that pharmacist IPs are truly integrated within the healthcare team and that 
the roles and responsibilities of all prescribers (medical and non-medical) are understood 
by all.  
 
Challenges to be overcome 
There is a great opportunity for NMP to make a real difference to professional practice 
and patient care globally. Legislation and models of care implemented vary between 
countries and it is possible that this variation will widen as more countries develop their 
own policies, structures and processes. While there are several significant matters which 
must be addressed, two key issues are: the need for sustainable models of care, and 
robust, rigorous evaluation research. 
 
There are many examples in healthcare of successful pilot projects not being sustained 
or failing once extended beyond successful pilot sites. There are also reports which 
indicate that a number of qualified non-medical prescribers have not prescribed. It is, 
therefore, extremely important to consider the theoretical basis for implementation of 
any major development or change in the delivery of services. Theory is also a key 
consideration in the United Kingdom Medical Research Council guidance on ‘Developing 
and implementing complex interventions’ [Craig et al. 2008]. One theory which is 
gaining in credibility in health related innovation is Normalization Process Theory (NPT). 
NPT is a set of sociological tools developed by May et al., explaining ‘…the social 
processes through which new or modified practices of thinking, enacting and organising 
work are operationalised in healthcare and other institutionalised settings’ [May et al. 
2009a]. It focuses on how work practices become routinely embedded (normalized) in 
everyday routines, with those practices which are normalized being much more likely to 
be sustained, leading to the long-term desired outcomes.  
NPT offers an explanation of three obstacles: implementation - the social organisation of 
bringing practices into action; embedding - the process through which practices become 
incorporated routinely; and integration - the process by which practices are sustained 
[May et al. 2009a, May et al. 2009b]. NPT proposes that practices are embedded 
routinely as the result of people working individually and collectively to implement them. 
Implementation is operationalised through four constructs of:  
 coherence, which relates to the sense-making work that people do individually 
and collectively 
 cognitive participation, relational work that people do to build and sustain a 
community of practice 
 collective action, operational work that people do to enact a set of practices 
 reflexive monitoring, appraisal work that people do to assess and understand the 
ways that a new set of practices affect them and others around them. 
 
Implementing NMP into any health system is likely to be complex when considering the 
number of different health professionals involved, the different processes and 
technological systems, the central role of the patient and influences of families, friends, 
carers, and many other factors which could impact negatively on the implementation and 
sustainability of NMP. Consider the situation where NMP is to be implemented in primary 
care. Patients will undoubtedly be going to interact with many health professionals and 
may well have more than one prescriber. For example, a medical prescriber may 
prescribe during a consultation for an acute condition or an acute worsening of a chronic 
condition. A nurse IP may manage a specific medical condition such as type 2 diabetes 
mellitus and the pharmacist IP may review and alter all chronic medicines. There is great 
potential for confusion which could lead to negative patient outcomes. 
Applying the principles of NPT and considering the constructs should enable clear 
coherence, understanding and shared decision making of all policy makers, managers, 
leaders, health professionals and patients. Cognitive participation should result in 
organised individuals working together systematically for collective action with clearly 
specified roles of health professionals, prescribers, patients and pathways of care. The 
final construct of reflexive monitoring should ensure that there is appropriate appraisal 
of the structures, processes and outcomes of NMP. This would facilitate successful 
implementation from all the different perspectives involved and sustainability of NMP. 
Returning to the example of Scotland and pharmacist prescribing, much effort is being 
expended on the governance structures to ensure coherence at all levels, cognitive 
participation, collective action and reflexive monitoring [The Scottish Government, 
2013]. This is being effected through a programme of widespread engagement facilitated 
by several interlinked workstreams, an overarching reference group and a management 
group. Emphasis being is placed on the active involvement of stakeholders (e.g. patient 
groups, health professionals, managers, leader, policy makers, academics, researchers 
etc.) and rapid communication of developments.   
 
The second issue which relates directly to reflexive monitoring is concerned with the 
necessity for robust and rigorous evaluation. While evaluation based research studies are 
considered to provide a lower level of evidence compared to findings derived from RCTs 
and associated systematic reviews and meta-analyses, evaluation designs are based on 
real life settings and practice. Furthermore, as NMP becomes adopted into legislation and 
practice, it is less likely that policy makers, senior managers and research funders will 
support RCT designs.  
The UK Health Foundation highlights three different definitions of evaluation which they 
consider relevant to health: the process of determining the merit, worth or value of 
something; using systematic, data-based inquiries about whatever is being evaluated; 
and a process undertaken for purposes of improvement, decision making, 
enlightenment, persuasion [The Health Foundation, 2015]. Robust and rigorous 
evaluation will provide valid, reliable and trustworthy data about how, why and when 
services are working (or not working). Better Evaluation is an ‘international collaboration 
to improve evaluation practice and theory by sharing and generating information about 
options (methods or processes) and approaches’ [Better Evaluation, 2016]. There are 
seven clusters of evaluation tasks: managing an evaluation or evaluation system; 
defining what is to be evaluated; framing the boundaries for the evaluation; describing 
activities, outcomes, impacts and context; understanding causes of outcomes and 
impacts; synthesising data from one or more evaluations; and reporting and supporting 
use of findings.  
There are multiple approaches to evaluation, some examples being: case studies, 
focused on understanding a unit (e.g. NMP site) in its context, employing qualitative, 
quantitative and mixed methodologies; participatory action research, which involves 
practitioners in the research process from the initial design of the project through data 
gathering and analysis to final conclusions; and realist evaluation. In 1997, Pawson and 
Tilley developed the first realist evaluation approach based on the question, ‘what works, 
for whom, in what respects, to what extent, in what contexts, and how?’ [Pawson et al. 
1997]. This approach differs from others in that it is grounded in theory, is claimed to be 
suited to assessing (a form of theory driven evaluation) and hence may be relevant to 
consider if using a theory such as NPT to facilitate implementation and sustainability. As 
with other evaluation approaches, the methodology may be qualitative, quantitative or 
mixed. However, alongside consideration of the evaluation approach, attention should be 
paid to who conducts the evaluation, when it should be conducted, and how to use the 
findings. Evaluation of NMP must consider all perspectives and while there are many 
examples of such evaluations, most are small scale, tend to focus on a limited number of 
perspectives, and often omit any theoretical underpinning to data collection, analysis or 
interpretation.  
Paying attention to these twin issues of intervention, normalization for sustainability and 
producing robust and rigorous evaluation data will greatly enhance NMP realisation 
globally.  
 
Conclusion 
Many countries have implemented NMP and these models of care are now being 
considered by others across the globe. Given that prescribing is a complex task with high 
potential for error, evidence of NMP outcomes is warranted. While there are a number of 
systematic reviews on aspects of NMP, there is a lack of evidence of prescribing safety, 
and clinical and cost effectiveness. The strategic approach of the Scottish Government to 
the implementation of pharmacist prescribing on a large scale could inform other 
countries as they implement and extend NMP. There are many challenges to 
implementing NMP into working practice; two key challenges are the need for 
sustainable models of care and evaluation research. These challenges could be met by 
considering the theoretical basis for NMP developments, and robust and rigorous 
evaluation to provide valid, reliable and trustworthy data about how, why and when 
services are working (or not working) to inform further developments. 
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